Skip to main content

Table 4 Results for screening ten HCW on day 15–39 of having symptoms

From: Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis

Option

Net cost

∆Cost

QALYs lost

∆QALYs lost

ICER ($/QALYs)

No Test

$11

n/a

0.00027

n/a

n/a

Only Ag

$61

$49

0.00025

0.00001

$3,909,046

Only IgG

$431

$420

0.00026

0.00001

$37,917,445

IgG, if positive PCR

$483

$472

0.00026

0.00001

$42,650,284

Only PCR

$522

$511

0.00028

− 0.00001

Dominated

IgG + PCR

$941

$930

0.00026

0.00001

$84,011,883

  1. No infected individuals have viable virus at this time and positive PCR test results are treated as false positives; does not indicate isolation
  2. Ag: antigen; ICER: incremental cost-effectiveness ratio; IgG: immunoglobulin G; PCR: polymerase chain reaction; QALY: quality-adjusted life year; ∆: difference
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us